Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05556200 | A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs | unknown | Phase 2 | 58 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05809024 | Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy | unknown | Phase 4 | 100 | Yongsheng WangOTHER | 1 | Apr 12, 2023 |
| NCT05806671 | Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT05758948 | Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer | unknown | — | 101 | Hellenic Cooperative Oncology GroupOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT05746728 | Surufatinib Combined With Tislelizumab in the Second-line and Further Treatment of Triple-negative Breast Cancer | unknown | Phase 1 / Phase 2 | 45 | Huihua XiongOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT05800197 | Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia(NEMO) | unknown | — | 300 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT05800756 | Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer | unknown | Phase 2 | 30 | Yantai Yuhuangding HospitalOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT04821570 | To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment(CANINE) | unknown | — | 500 | University of Kansas Medical CenterOTHER | 1 | Apr 4, 2023 | clinicaltrials |
| NCT05594082 | Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer | unknown | — | 150 | Fudan UniversityOTHER | 1 | Apr 4, 2023 | clinicaltrials |
| NCT05737446 | Oxygen Partial Pressure After Breast Cancer Surgery | unknown | — | 60 | Umeå UniversityOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05790096 | Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy | unknown | Phase 3 | 60 | Blau Farmaceutica S.A.INDUSTRY | 0 | Mar 29, 2023 | clinicaltrials |
| NCT00412022 | HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.(HOBOE) | unknown | Phase 3 | 1,294 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT00431704 | VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer(VinCaT) | unknown | Phase 2 | 39 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT04953377 | PFMT Educational Intervention for Patients With Advancer Breast Cancer | unknown | N/A | 42 | OnkologikoaOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT05453591 | Investigation of Urinary Biomarkers for the Detection of Breast Cancer(URODETECT-WP3) | unknown | N/A | 200 | Novosanis NVINDUSTRY | 1 | Mar 24, 2023 | clinicaltrials |
| NCT05782504 | Patient-centered Breast Cancer Teleprehabilitation(BC-PREHAB) | unknown | N/A | 50 | Universitair Ziekenhuis BrusselOTHER | 1 | Mar 23, 2023 | clinicaltrials |
| NCT00470236 | Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast(DCIS) | unknown | N/A | 1,608 | Trans Tasman Radiation Oncology GroupOTHER | 11 | Mar 22, 2023 | clinicaltrials |
| NCT05456373 | Intraoperative Use of ClearEdge Device in Breast Conserving Surgery | unknown | N/A | 288 | LS BioPathINDUSTRY | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05633342 | Project CADENCE (CAncer Detected Early caN be CurEd)(CADENCE) | unknown | — | 15,000 | MiRXES Pte LtdINDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05775575 | A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer | unknown | Phase 1 / Phase 2 | 65 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT04924699 | A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 / Phase 3 | 350 | Shanghai Miracogen Inc.INDUSTRY | 1 | Mar 17, 2023 | clinicaltrials |
| NCT05771337 | Circular RNA and Chemerin in Breast Cancer Patient | unknown | — | 80 | Assiut UniversityOTHER | 0 | Mar 16, 2023 | clinicaltrials |
| NCT05769491 | Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Mar 15, 2023 | clinicaltrials |
| NCT05767931 | Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer | unknown | — | 60 | Peking UniversityOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT05768451 | Ultrasound Radiomics for Predicting Breast Cancer and Axillary Lymph Node Metastasis | unknown | — | 200 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 0 | Mar 14, 2023 | clinicaltrials |
| NCT05765916 | An Online Psychosocial Intervention for Fear of Cancer Recurrence in Breast Cancer Survivors | unknown | N/A | 244 | National University of SingaporeOTHER | 1 | Mar 13, 2023 | clinicaltrials |
| NCT05515289 | Study of SHR6390 in Renal Insufficiency and Healthy Subjects | unknown | Phase 1 | 30 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Mar 10, 2023 | clinicaltrials |
| NCT05763472 | Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation(Gen-eva) | unknown | — | 10 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 10, 2023 | clinicaltrials |
| NCT04365790 | Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma | unknown | — | 500 | Hellenic Cooperative Oncology GroupOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT04403984 | Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes | unknown | — | 750 | Hellenic Cooperative Oncology GroupOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT05429866 | Immunological Variables Associated to ICI Toxicity in Cancer Patients | unknown | Phase 2 | 441 | Jules Bordet InstituteOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT05754060 | Cognitive Processing Slowness as a Marker of Cognitive Impairment in Non-central Nervous System Cancer Patients(RIVAGE) | unknown | — | 200 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Mar 8, 2023 | clinicaltrials |
| NCT05760222 | Acupuncture Treatment of Vasomotor Symptoms in Breast Cancer Patients(Acu-HOTFLASH) | unknown | N/A | 90 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT03772353 | Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer(PLEASURABLE) | unknown | Phase 1 / Phase 2 | 59 | Fudan UniversityOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT05628077 | Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors | unknown | — | 1,200 | Peking University People's HospitalOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT03475953 | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE) | unknown | Phase 1 / Phase 2 | 747 | Institut BergoniéOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT05753865 | A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound) | unknown | Phase 3 | 454 | CSPC Ouyi Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 3, 2023 | clinicaltrials |
| NCT05750693 | PIK3CA in HER2+ BC and pCR Trial | unknown | N/A | 58 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 2, 2023 | clinicaltrials |
| NCT05749016 | Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer | unknown | Phase 2 | 30 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT05749575 | Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer. | unknown | Phase 2 | 28 | Sun Yat-sen UniversityOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT05670925 | A Trial Exploring the Opportune Administration of Nab-paclitaxel in the First Line Treatment, Camrelizumab Combined With Nab-paclitaxel and Famitinib, of TNBC. | unknown | Phase 2 | 46 | Fudan UniversityOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT05747313 | Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer | unknown | Phase 1 / Phase 2 | 40 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT05747326 | Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer | unknown | Phase 2 | 30 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT04846972 | Facilitate and Sustain Return to Work After Breast Cancer(FASTRACS-RCT) | unknown | — | 420 | Hospices Civils de LyonOTHER | 1 | Feb 27, 2023 | clinicaltrials |
| NCT05744518 | Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI | unknown | — | 80 | Fudan UniversityOTHER | 1 | Feb 27, 2023 | clinicaltrials |
| NCT05417048 | Clinical Study of Glycosylated Extracellular Vesicles for Early Diagnosis of Breast Cancer | unknown | — | 420 | Peking UniversityOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05728632 | Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines(CONTROL) | unknown | Phase 3 | 80 | Giulio StefaniniOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT04226222 | Bringing of PET-TDM FDG in the Determination of the Characteristics of Primary Mammary Tumors TrIple Negatives(FICTION) | unknown | — | 132 | Institut Cancerologie de l'OuestOTHER | 1 | Feb 21, 2023 | clinicaltrials |
Data updated 24 days agoSource updated Apr 12, 2023source: clinicaltrials